GoodCap Pharmaceuticals
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
45 Rockefeller Plz Ste 2000, New York Ci...Website
www.goodcap.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GoodCap Pharmaceuticals
Founded in 2018 with a deeply rooted commitment to enhancing human health, GoodCap is focused on targeting neuroinflammation to treat psychiatric and neurodegenerative disorders. Our mission is to provide clinicians and patients with unparalleled insights into complex neurological conditions. Our innovative approach is not just about treating symptoms; its about fundamentally understanding and disrupting inflammation and degenerative disease processes at their core, offering hope and improved quality of life for millions affected by these challenging conditions.Explore more
GoodCap Pharmaceuticals Org Chart
DH
Co-Founder & Chief Information Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GoodCap Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on GoodCap Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when GoodCap Pharmaceuticals launches new products
Check out if GoodCap Pharmaceuticals is spiking on competitors!
Click to see if GoodCap Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GoodCap Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if GoodCap Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once GoodCap Pharmaceuticals has new funding data
GoodCap Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at GoodCap Pharmaceuticals
Find more new buyers
Compare Similar Companies to GoodCap Pharmaceuticals
Compare insights from companies similar to GoodCap Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GoodCap Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GoodCap Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GoodCap Pharmaceuticals.
GoodCap Pharmaceuticals Tech Stack
A closer look at the technologies used by GoodCap Pharmaceuticals
See more technologies
GoodCap Pharmaceuticals News & Media
GoodCap Announces the Appointment of Dr. Laura Targownik to Its Scientific Advisory Board
Toronto, Ontario--(Newsfile Corp. - January 17, 2023) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), is pleased to announce the appointment of Dr. Laura Targownik, MD, to its Scientific Advisory Board.Dr. Targownik is currently a Clinician Researcher in the Mount Sinai Hospital Inflammatory Bowel Disease Clinic and is a member of the Zane Cohen Centre for Gastrointestinal Research. She is also the Director for the University of Toronto Division of Gastroenterology and Hepatology anGoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders
Toronto, Ontario--(Newsfile Corp. - November 10, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), a biopharmaceutical company developing low-dose psychedelic therapies, is pleased to announce that the Natural Sciences and Engineering Research Council of Canada (NSERC) has awarded an Alliance Grant to its research partner at the University of Toronto (the "University") for $237,339, effective October 2022 to be paid through 2023. The research is focused on furthering the evaluat
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GoodCap Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2018 with a deeply rooted commitment to enhancing human health, GoodCap is focused on targeting neuroinflammation to treat psychiatric and neurodegenerative disorders. Our mission is to provide clinicians and patients with unparalleled insights into complex neurological conditions. Our innovative approach is not just about treating sympt... Read More
